SCHEMBL4928103

SCHEMBL4928103

CN(Cc1ccccc1)C(=O)CCC[C@H](N)C(=O)NO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
KMT2A Q03164 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 2/20 0.45
POLB P06746 2/20 0.45
FOLH1 Q04609 2/20 0.45
MMP1 P03956 2/20 0.44
MMP3 P08254 2/20 0.44
MMP7 P09237 1/20 0.44
MMP9 P14780 1/20 0.44
BCHE P06276 1/20 0.44
ACHE P22303 1/20 0.44
LTA4H P09960 1/20 0.44
CA12 O43570 1/20 0.43
CA9 Q16790 1/20 0.43
TSHR P16473 1/20 0.43
MEN1 O00255 1/20 0.42
CDK4 P11802 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4934691 0.92 NPC1 (0.60) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL4934705 0.92 NPC1 (0.60) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL8226894 0.80 NPC1 (0.66) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL19457041 0.79 NPC1 (0.70) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL4072151 0.79 NPC1 (0.85) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL5080215 0.78 NPC1 (0.68) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL5080211 0.78 NPC1 (0.68) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL23833849 0.77 NPC1 (0.66) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
SCHEMBL25507617 0.76 NPC1 (0.60) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL30420189 0.75 NPC1 (0.59) NPC1RAB9AKMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 NPC1 2718/4885RAB9A 1921/4885KMT2A 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.